Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.
<h4>Background</h4>Systemic inflammatory response syndrome is a fatal disease because of multiple organ failure. Acute kidney injury is a serious complication of systemic inflammatory response syndrome and its genesis is still unclear posing a difficulty for an effective treatment. Aldos...
Guardado en:
Autores principales: | Kazunori Takahashi, Hiroki Mizukami, Kosuke Kamata, Wataru Inaba, Noriaki Kato, Chihiro Hibi, Soroku Yagihashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d20adac2b2f748449162afe6f59ca1e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway
por: Haifei Xie, et al.
Publicado: (2022) -
A new approach to control the enigmatic activity of aldose reductase.
por: Antonella Del-Corso, et al.
Publicado: (2013) -
Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity
por: Himangshu Sonowal, et al.
Publicado: (2017) -
A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity
por: Sever Belgin, et al.
Publicado: (2021) -
Efficacy and safety of aldose reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy: systematic review and meta-analysis.
por: Xin Hu, et al.
Publicado: (2014)